Science News: Pharma Corruption, Dangers of Antidepressants, And More
No se pudo agregar al carrito
Solo puedes tener X títulos en el carrito para realizar el pago.
Add to Cart failed.
Por favor prueba de nuevo más tarde
Error al Agregar a Lista de Deseos.
Por favor prueba de nuevo más tarde
Error al eliminar de la lista de deseos.
Por favor prueba de nuevo más tarde
Error al añadir a tu biblioteca
Por favor intenta de nuevo
Error al seguir el podcast
Intenta nuevamente
Error al dejar de seguir el podcast
Intenta nuevamente
Science News: Pharma Corruption, Dangers of Antidepressants, And More
-
Narrado por:
-
De:
Acerca de esta escucha
In this 30-minute podcast, Peter Simons reports on the latest scientific articles in psychiatry. The goal is to provide more detail than is usually found in conventional research news and to help listeners understand how to interpret the findings.
Articles covered in this podcast include:
- How the mental health app Cerebral is facing accusations of dangerous and unethical practices;
- How Biogen withdrew its European application for failed Alzheimer’s drug aducanumab;
- How pharma company Cassava was the subject of a New York Times exposé on its Alzheimer’s research and outcome data;
- How social media influencers are the new pharma marketers;
- Researchers document how psychiatric textbooks and reviews endorsed the chemical imbalance myth;
- A study finding that antidepressants don’t improve quality of life;
- A study on antidepressants’ dangerous effects on the fetus if taken during pregnancy;
- A paper explaining the difference between antidepressant withdrawal and relapse;
- A paper on the dangers of benzodiazepine withdrawal;
- A study finding that a sense of meaningfulness in life protects against mental distress; and
- A paper by Joanna Moncrieff on the ties between the commodified mental health system and neoliberal capitalism.
Todavía no hay opiniones